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AbstrAct
Objective current methods used for forecasting workforce 
requirements in rheumatology are disparate, as are 
the parameters incorporated into workforce projection 
studies. the objective of these european league against 
rheumatism (eUlar points to consider (Ptc) is to guide 
future workforce studies in adult rheumatology in order to 
produce valid and reliable manpower estimates.
Methods the eUlar Standardised Operating Procedures 
were followed. a multidisciplinary task force with experts 
including patients with rheumatic diseases from 11 eUlar 
countries and the USa was assembled. a systematic 
literature review (Slr) was conducted to retrieve 
workforce models in rheumatology and other medical 
fields. Ptc were based on expert opinion informed by 
the Slr, followed by group discussions with consensus 
obtained through informal voting. the level of agreement 
with the Ptc was voted anonymously.
Results a total of 10 Ptc were formulated. the task 
force recommends models integrating supply (=workforce 
available in rheumatology), demand (=health services 
requested by the population) and need (=health services 
that are considered appropriate to serve the population). 
in general, projections of workforce requirements should 
consider all factors relevant for current and future 
workload in rheumatology inside and outside of direct 
patient care. Forecasts of workforce supply should 
consider demography and attrition of rheumatologists, 
as well as the effects of new developments in 
healthcare. Predictions of future need/demand should 
take demographic, sociocultural and epidemiological 
development of the population into account.
Conclusion these eUlar-endorsed Ptc will provide 
guidance on the methodology and the parameters to be 
applied in future national and international workforce 
requirement studies in rheumatology.
InTROduCTIOn
The European League Against Rheumatism 
(EULAR) has been developing strategies and 
recommendations for early referral, diagnosis 
and management of patients with rheumatic 
and musculoskeletal diseases (RMDs) in 
order to prevent disease-related damage 
from the early phase of the disease eventually 
causing functional restrictions, comorbidities 
and psychosocial isolation.1–5 In several coun-
tries, it is difficult to implement these recom-
mendations because of limited manpower 
resources; rather, there are long waiting lists 
for a new patient rheumatology appoint-
ment.6 In addition, the demand for rheuma-
tology services is expected to increase in the 
next years for several reasons: (1) the preva-
lence of RMDs is increasing due to increasing 
life expectancy in the general population, 
Key messages
What is already known about this subject?
 ► calculation of manpower requirement in rheumatol-
ogy is the basis for adequate service provision to the 
population in future.
 ► current methods used for forecasting manpower 
are disparate resulting in projections that vary by a 
factor of five.
What does this study add?
 ► these are first european league against 
rheumatism (eUlar)–endorsed ‘points to consider’ 
(Ptc) providing a framework for future workforce 
models in rheumatology. these Ptc might also be 
applied by other medical disciplines.
 ► this article highlights areas of uncertainty and points 
to aspects that require further research.
How might this impact on clinical practice?
 ► it is anticipated that eUlar, national societies and 
healthcare planners will use these Ptc as a basis for 
future workforce studies in rheumatology.
 ► the results of workforce studies should ultimately be 
translated into political actions assuring a sufficient 
number of rheumatologists to serve patients suffer-
ing from rheumatic and musculoskeletal diseases.
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the introduction of new classification/diagnostic criteria 
capturing patients earlier in the disease and new treat-
ment options improving patients’ survival.7–9 (2) More 
healthcare resources are required for individual patients 
because of new therapies and novel tests for diagnosis 
and monitoring.10 11
Questions such as “how many rheumatologists are 
needed to meet current and future population needs?” 
have to be answered in order to adequately counsel 
future healthcare planners. Current methods used for 
forecasting manpower in rheumatology are disparate, as 
are the variables incorporated into projection models.12 
The resulting projections from available studies vary by 
a factor of five (from 0.7/100 000 population in the UK 
to 3.5/100 000 in Spain), and appraisal of these studies 
is hampered by a lack of standardisation of methods for 
prediction. Hence, these publications do not provide a 
sound basis for healthcare policy recommendations and 
advice.12
The broad objective of this project was to provide 
EULAR-endorsed ‘points to consider’ (PTC) for the 
methodology of future workforce requirement studies 
for rheumatologists. Studies based on these PTC should 
guide political actions in order to achieve a supply of 
rheumatologists sufficient to meet EULAR’s goals of early 
diagnosis and treatment of patients with RMDs.
MeTHOds
After approval by the EULAR Executive Committee, the 
convenors (CD, FB) and the methodologist (SR) led a 
task force guided by the 2014 updated EULAR Standard-
ised Operating Procedures.13 The 20 task force members 
consisted of rheumatologists, epidemiologists, a method-
ologist, a health professional, and representatives from 
People with Arthritis/Rheumatism across Europe and 
EMerging EUlar NETwork from 11 EULAR countries 
and the USA. All members disclosed their conflicts of 
interest upfront. Two task force meetings took place. At 
the first meeting, the task force agreed on the following 
key questions: (1) “Is there a standardised approach/
best practice model in workforce requirement studies 
for rheumatologists and other medical fields concerning 
model selection, analysis, consideration of heterogeneity, 
stakeholder involvement, parameters included and data 
retrieval?”; (2) “What is the predictive value of identified 
workforce requirement studies?”
A systematic literature review (SLR) was conducted by 
two fellows (PP, JU) on workforce prediction studies in 
rheumatology and SLRs of studies from other medical 
fields.14 The evidence and quality assessment of retrieved 
studies was presented to the task force in the form of 
tables. A new tool for the appraisal of the quality of work-
force studies was developed as part of this project. This 
tool and the SLR are published separately;14 however, 
they form an integral and inseparable part of the whole 
project together with the present PTC and should be 
read as such.
At the second meeting, the task force formulated the 
PTC based on evidence and expert opinion in a process 
of discussion and consensus, followed by final voting. 
Consensus was accepted if >75% (>67%, >50%) of the 
members voted in favour of the PTC at the first (second, 
third, respectively) round.
Finally, each task force member anonymously indicated 
the level of agreement via email (LoA; numeric rating 
scale ranging from 0=do not agree to 10=fully agree). 
The mean and SD of the LoA as well as the percentage of 
task force members with an agreement ≥8 are presented.
Based on the gaps in evidence and the issues of 
controversy, a research agenda was formulated. The 
final manuscript was reviewed and approved by all task 
force members and approved by the EULAR Executive 
Committee.
ResulTs
These PTC are intended to guide future workforce 
requirement studies aiming to provide workforce targets 
for adult rheumatologists. We do not refer to models 
calculating the need/demand and supply of non-physi-
cian health professionals or other medical fields involved 
in the management of patients with RMDs. The targeted 
audiences are healthcare planners, epidemiologists, 
health professionals, politicians, rheumatologists, payers 
and patient organisations. Stakeholder involvement in 
workforce studies is essential; however, the perception of 
which stakeholders are relevant may vary between coun-
tries. The task force suggests including representatives 
from different geographical regions and involving at 
minimum rheumatologists, patient representatives, poli-
ticians and healthcare planners. Stakeholders have an 
advisory role in the selection of model and parameters, 
interpretation as well as consideration of scenarios for 
uncertainty analysis. They may serve as interviewees for 
qualitative (sub)studies when empirical data are absent.15
Points to consider
A total of 10 PTC have been formulated, which are 
summarised in table 1 and discussed in detail below.
Ptc 1: Workforce models should integrate supply, demand and 
need of the respective geopolitical entity (eg, municipality, region, 
state, country), and should express results as full-time equivalents 
and as number of rheumatologists
‘Supply’ is the workforce available to rheumatology, 
‘demand’ is defined as health services requested by 
the population and ‘need’ reflects the health services 
considered adequate to serve the population.16 17 Need 
and demand are closely related; however, they do 
not necessarily overlap since there may be a higher or 
lower demand for services than what is deemed appro-
priate in the particular healthcare setting. Supply and 
demand interact, that is, new services may increase 
demand (supply-induced demand) and vice versa.15 
The majority of workforce studies in rheumatology have 
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Table 1 EULAR points to consider for the conduction of workforce requirement studies in rheumatology
Number Point to consider LoA LoE
1 Workforce models should integrate supply, demand and need of the respective geopolitical entity (eg, 
municipality, region, state, country) and should express results as full-time equivalents and as number of 
rheumatologists
9.5 (0.9)
95% ≥8
5
2 Workforce models should provide projections over a period of 5–15 years 9.1 (1.1)
90% ≥8
5
3 Workforce models should not assume a current balance between supply and need 9.6 (0.7)
100% ≥8
5
4 Workforce models should, where possible, rely on several data sources and include uncertainty analyses 9.8 (0.4)
100% ≥8
5
5 Workforce models should be regularly updated; updates should include an analysis of the actual performance 
(ie, prediction validity) of the previous model
9.5 (0.6)
100% ≥8
5
6 Workforce need for patient care should be based on the prevalence and referral rates of diseases managed by 
rheumatologists as well as on an estimation of time needed per patient
9.7 (0.7)
100% ≥8
5
7 Workforce need for patient care should consider current and future demographics, sociocultural characteristics 
of the population and disease patterns
9.5 (0.9)
95% ≥8
5
8 Workforce need and supply should consider work outside rheumatology patient care (eg, administrative tasks, 
research, teaching, non-rheumatological disease management), as well as patient care performed by other 
health professionals in rheumatology
9.4 (0.9)
95% ≥8
5
9 Workforce supply should account for demographic composition of rheumatologists, the number of 
rheumatologists entering and leaving the workforce, and generational attitudes of rheumatologists towards 
scope of practice and work–life balance
9.1 (2.3)
85% ≥8
5
10 Workforce models should consider the effects of medical developments, including new technologies, 
medications, artificial intelligence and e-health, on demand and supply
9.4 (1.1)
85% ≥8
5
Numbers in column ‘LoA’ indicate the mean and SD (in parentheses) of the LoA, as well as the percentage of task force members with an agreement 
≥8. None of the studies identified corresponded to any of the categories of Oxford Centre for Evidence-Based Medicine.64 Evidence level was 
therefore set as ‘5’, which is the lowest level of evidence.
LoA, level of agreement; LoE, level of evidence
used integrated models and studied (at least in part) the 
factors influencing each of these factors.14
Effective workforce planning needs to consider 
regional heterogeneity of supply, demand and need, 
which may all vary across countries, states, regions and 
rural versus urban areas.17–19
Results of workforce requirement studies should be 
provided in full-time equivalents and head counts per 
reference population (eg, n/100 000 people) in order to 
take part-time work and time spent on non-clinical work 
into account, respectively.
Ptc 2: Workforce models should provide projections over a period 
of 5–15 years
An adequate period for prediction is pivotal in order 
to enable the translation of study results into political 
actions that will fill anticipated workforce gaps or reduce 
surplus if any exists.
Several workforce requirement studies in rheuma-
tology provided only a baseline assessment (and are thus 
not true prediction studies), whereas others covered time 
frames between 5 and 25 years14 with some providing 
estimates for every 5 years.17 20 21 The Handbook on 
Health Workforce Planning methodologies across EU 
countries suggests a period of 12–18 years for workforce 
studies in healthcare, and the Health Workforce Plan-
ning in OECD Countries proposes a time frame of 15–20 
years.15 16 These reports consider the total length of 
medical training (medical school and specialisation) plus 
the time for implementation of political changes. The 
task force was of the opinion that for workforce studies in 
rheumatology, a shorter period would be more accurate 
because political actions will mostly occur at the level of 
specialisation, for example by regulating the number of 
training posts for rheumatologists. The average training 
time to become a rheumatologist after graduation from 
medical school varies between 3 and 8 years in Western 
countries.22
Ptc 3: Workforce models should not assume a current balance 
between supply and need
The majority of workforce models in rheumatology 
assumed, mostly for simplicity, a balance between supply 
and need at baseline.14 This ignores the possibility of an 
oversupply or shortage of workforce relative to the actual 
need of the population, particularly in certain geograph-
ical areas, and may lead to further under or overestima-
tion of future workforce requirements in rheumatology.
There are several possibilities to assess whether current 
supply meets demand, for example by analysing vacan-
cies (1%–3% is considered normal), waiting lists, locum 
lists, regional distribution and/or immigration trends of 
rheumatologists.15 23 Any current gap between healthcare 
use rates and need as recommended by clinical guide-
lines might also be an indicator of whether workforce 
supply meets population need (after correcting for other 
barriers of implementation such as lack of training or 
remuneration).16 Regrettably, the implementation of 
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EULAR recommendations is still incomplete in several 
countries.24
Ptc 4: Workforce models should, where possible, rely on several 
data sources and include uncertainty analyses
There was some discussion whether a PTC on data 
sources is required because prediction models should be 
based on solid evidence. Many factors included in work-
force models are based on extrapolations and assump-
tions rather than on hard data because of the lack of 
studies. Therefore, the task force was of the opinion 
that prediction models should make use of several data 
sources. These constitute individual or aggregate data 
from observational studies including registries, but also 
surveys, expert consensus or other forms of qualitative 
research.15 16 Examples where qualitative studies provide 
valuable information are questions like: “What propor-
tion of patients with certain diseases should be managed 
by rheumatologists as opposed to other specialists?” or 
“What are the most important factors influencing supply 
and demand in a specific setting?” In contrast, param-
eters like disease prevalence or demographic changes 
of the population require an empirical basis. Given that 
data on these factors may be imprecise and heteroge-
neous, the confidence in estimates increases if data are 
gathered from several sources and reveal similar results.
The main goal of uncertainty analysis is to gain insight 
into which assumptions are most vulnerable and to 
understand the effect of modifying critical parameters on 
final estimates. It is generally expected that a workforce 
model results in better predictions if many parameters 
are considered25; however, a high number of assumptions 
might also limit the precision of the model.26 27
Ptc 5: Workforce models should be regularly updated; updates 
should include an analysis of the actual performance (ie, 
prediction validity) of the previous model
Although it seems implicit to update workforce models 
regularly, the task force decided to address this issue 
specifically. A regular update every 4 years at minimum 
is suggested, particularly if new data for the input varia-
bles become available. New clinical practice recommen-
dations, new regulations affecting working time (such 
as overtime rules) or retirement age of physicians are 
examples of factors that may have a dramatic impact on 
workforce prediction.28 29 Authors of workforce models 
should regularly investigate whether observed changes 
correspond to expected ones. Weaknesses of the model, 
model assumptions and implementation should be 
addressed if the plan is off track.15
In rheumatology, updates and assessment of workforce 
models have only been performed and reported from 
Germany and the USA, although not within the 4-year 
time frame.20 30 Both studies compared the overlap and 
divergence of estimates between the newer and the 
previous model.17 18 In the study of the U.S. Depart-
ment of Health and Human Services, face validation by 
experts, a ‘stress test’ for extreme values, external and 
predictive validation against other data sources (not used 
for the model) as well as a validation of results against 
other models were performed.31
Ptc 6: Workforce need for patient care should be based on 
the prevalence and referral rates of diseases managed by 
rheumatologists as well as on an estimation of time needed per 
patient
The task force unanimously agreed that the prevalence 
of diseases, the proportion of patients with a specific 
disease followed by rheumatologists as well as the time 
spent with an individual patient are the most important 
factors determining the workforce need in rheumatology. 
These factors, however, may be subject to large national 
and regional heterogeneity. In France, for example, 
rheumatologists follow many patients with degenerative 
RMDs, whereas in Germany, patients with these condi-
tions are mainly referred to orthopaedic surgeons and 
other specialists. Given the high prevalence of degener-
ative RMDs,32 even small variations in the assumptions 
related to these conditions may have a large impact on 
the prediction of workforce need.
The task force decided to use the overarching term ‘time 
needed per patient’ that covers several aspects related to 
patient care. While some workforce models included a 
rough estimate of the annual time needed for individual 
patients (eg, 3 hours/year for a patient with vasculitis),33 
others applied a more complex approach estimating the 
number and length of visits per patient/year considering 
the type of condition (eg, non-inflammatory vs inflamma-
tory) and the disease phase (new-onset vs stable disease/
remission).18 30 Other factors that should be considered 
are the type of visits (eg, onsite vs telephone/email 
consultations) as well as the time spent for technical 
procedures (eg, ultrasound) and interventions.
The task force recognised that it may be difficult to base 
estimates for these factors on empirical data; however, 
surveys as well as expert interviews might enable realistic 
assumptions.
Ptc 7: Workforce need for patient care should consider current 
and future demographics, sociocultural characteristics of the 
population and disease patterns
The majority of workforce studies in rheumatology took 
ageing of the population into account.14 The task force 
recommends also considering other aspects of population 
demographics such as (changes of) socioeconomic status 
as well as migration patterns. Growth of minority groups 
from a certain genetic background for example might 
lead to an increase of the prevalence of formerly rare 
diseases, and immigrants from certain countries might 
need greater medical attention due to neglected rheu-
matological disease, comorbidities or (latent) infections 
that have become uncommon in the Western world.34–36 
Ethnicity, social status and educational level have also an 
impact on disease outcomes and healthcare use across 
different diseases.37 38 The social view on health, the 
influence of the internet on health information and the 
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help-seeking behaviour for rheumatic complaints might 
influence the expected demand of health services.39–41 
Other demographic/social factors relevant to future 
healthcare need include obesity, smoking and nutrition 
trends, as these are risk factors for rheumatic diseases 
and their comorbidities.42–46
The expected evolution of diseases over time also 
needs to be considered. Factors such as longer life expec-
tancy increase the need for medical services whereas 
better disease outcomes (eg, lower disability) may have 
the opposite effect.47
Ptc 8: Workforce need and supply should consider work outside 
rheumatology patient care (eg, administrative tasks, research, 
teaching, non-rheumatologic disease management) as well 
as patient care performed by other health professionals in 
rheumatology
Rheumatologists work in patient care and also have tasks 
related to administration, teaching and research. In 
addition, they may perform clinical work outside rheu-
matology such as night shifts in departments of internal/
general medicine. The proportion of working time rheu-
matologists can spend on seeing patients with RMDs 
depends on the setting (eg, academic vs community 
hospital vs private practice) and on the national/regional 
regulations. In some countries such as Austria, rheuma-
tologists frequently work within larger departments of 
internal medicine; hence, they have only a few hours a 
week for rheumatology outpatient clinics while working 
most of the time as general internists.
Another aspect that needs to be considered is the possi-
bility of shifting clinical tasks from rheumatologists to 
general practitioners or other specialists (so called hori-
zontal substitution), and/or to delegate work to other 
non-physician health professionals such as advanced 
nurse practitioners and physician assistants (vertical 
substitution).15 While the task force was reluctant to make 
any recommendation about which tasks could be dele-
gated, an increasing task-shift can already be observed in 
several countries.48–51
Multidisciplinary team work such as co-joined outpa-
tient clinics (eg, with dermatologists, gastroenterologists, 
paediatricians etc) or meetings with other specialists 
(radiologists, physiotherapists, specialised nurses etc) 
may also change the total workload for rheumatologists 
and other professionals, while they aim at improving the 
quality of care.52–54
Ptc 9: Workforce supply should account for demographic 
composition of rheumatologists, the number of rheumatologists 
entering and leaving the workforce, and generational attitudes of 
rheumatologists towards scope of practice and work–life balance
Workforce models in rheumatology should consider 
expected retirement rates of rheumatologists, the 
lower number of visits performed by young rheuma-
tologists due to lack of experience, as well as part-time 
work (common for older and female rheumatologists). 
Female physicians have been shown to perform fewer 
patient visits than male physicians (by ~30% annually),55 
and part-time workers usually have the same tasks in 
administration as full-time workers resulting in a lower 
availability for clinical care. A change of the perception 
of work (and work–life balance) can also be observed 
in newer as compared with older generations, which 
affects the willingness to work full-time and overtime.56 57 
While these aspects do not directly impact the quality of 
care (which should always be kept at a high level), work-
force planners need to consider possible changes in the 
number of annual visits provided by individual rheuma-
tologists.
The most important individual factors influencing the 
number of rheumatologists entering and leaving the 
market are training and retirement, respectively. Small 
variations in these parameters (eg, increment of retire-
ment age) may have considerable effects on workforce 
supply.28 A solid projection of these parameters is there-
fore essential, as opposed to what has mostly been done.14 
Other factors influencing workforce supply are migra-
tion and attrition. Attrition may be within the profession 
(ie, rheumatologists change to another specialty) or to 
another profession. Changes of working conditions such 
as altered salary or career prospects, modification of 
retirement age rules and workload affect the desirability 
of medical professions and thus supply, motivation and 
productivity of rheumatologists.58
Ptc 10: Workforce models should consider the effects 
of medical developments, including new technologies, 
medications, artificial intelligence and e-health, on demand and 
supply
Ongoing medical developments such as availability of 
new medications, new or improved technical devices for 
diagnosis and monitoring as well as novel interventional 
procedures directly or indirectly influence the demand 
for workforce in rheumatology. New treatment options 
for example may improve the outcome of patients 
with RMDs thereby directly modifying the demand for 
medical services.47 Ultrasound and other diagnostic tech-
niques, while informing medical decisions, increase the 
time needed for an individual patient visit.11 Technical 
developments alleviating clinical documentation may 
expand the time available to patients, and new qualifica-
tion and training models of health professionals may lead 
to a higher task shift thus increasing the time resources of 
physicians to see more patients.59
The task force decided to mention e-health separately 
because of its importance for future healthcare and 
because it may be considered a ‘medical’ development 
only in part. Telemedicine, ‘app’-based self-management 
or similar innovations may all reduce the need for face-
to-face visits.60 At the same time, increasing ‘self-diag-
nosis’ of patients by such systems might also increase the 
demand for medical services.41 61
Based on the discussions and the areas of uncertainty, 
a research agenda has been proposed, depicted in box 1.
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box 1 Research agenda
 ► Stimulate national and international rheumatology societies to run 
workforce prediction studies following these points to consider.
 ► evaluate and compare the quality of workforce studies performed 
before and after these eUlar points to consider.
 ► conduct workforce studies integrating workforce calculation for 
rheumatologists, other medical fields and other non-physician 
health professionals.
 ► Determine the optimal number of factors to be included in work-
force calculation models.
 ► identify the most influential factors to be included in workforce 
calculation models, and quantify the relative importance of various 
items (weighting) included in workforce models.
 ► Determine the optimal number and type of data sources.
 ► Develop methods for the validation of workforce models.
 ► Determine the best statistical approach for model calculation and 
uncertainty analysis.
dIsCussIOn
These are the first EULAR-endorsed PTC providing a 
framework for future workforce models in rheumatology, 
which may eventually be applied by other medical disci-
plines. The task force recognised that health workforce 
planning is not an exact quantification science; rather, 
it is an iterative process in which the ability to measure 
and predict improves over time.16 Translation of work-
force models into political actions, regular monitoring 
of whether observed changes correspond to predictions, 
as well as ongoing adaption of parameters to reality are 
essential to obtain a practical and useful model (‘plan–
do–check–adjust’).62
Several recommendations were based on expert 
opinion because evidence was limited or absent for many 
aspects.14 This has been acknowledged both in the PTC 
and in the research agenda, which should stimulate 
further research to fill the gaps of knowledge in the field.
The present PTC are intended to be applied in future 
models predicting the requirements for rheumatologist 
manpower. Complex studies calculating the number of 
all medical professionals required for the care of patients 
with RMDs (including general practitioners, other 
specialists and health professionals) are not within the 
scope of this work. Given the dynamic development of 
task shifting from one to another profession, models 
focused on rheumatologists assume a sufficient supply of 
other health professionals, which does not always corre-
spond to reality.17 63 On the other hand, complex studies 
might lose precision because several estimations and 
extrapolations are necessary to generate the model.
The task force discussed and acknowledged the impor-
tance of economic development and health budget on 
supply and demand/need but did not achieve a consensus 
to formulate a specific proposition.15 The health budget 
may determine the investments in regional health 
services, the opening of new health centres (which might 
mainly influence demand) and replacement of health 
professionals that have retired. In case of a shortage of 
specialists (and assuming budget is available), higher 
expenditures for specialised training, improved working 
conditions and wages are potential political levers to 
increase the influx of professionals.
It is anticipated that EULAR, national societies and 
healthcare planners will use these PTC as a basis for 
future workforce studies in rheumatology. These should 
ultimately be translated into political actions to assure 
a sufficient number of rheumatologists at EU, national 
and regional levels to adequately serve patients suffering 
from RMDs.
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